This occurred despite no differences in fatty acid oxidation, nor in the OXPHOS protein expression or mRNA expression of CYC1, PPARGC1A, CPT1B or PDK4 in myotubes from severely obese donors with type 2 diabetes compared to cells from severely obese non-diabetic donors. This evidence concerns the gene CPT1B and type 2 diabetes mellitus.